Overview
Anna Fariss is a Radiation Oncologist in Manchester, New Hampshire. Dr. Fariss is rated as an Experienced provider by MediFind in the treatment of Metastatic Pleural Tumor. Her top areas of expertise are Angiosarcoma, Vulvar Cancer, Endometrial Cancer, and Breast Cancer. Dr. Fariss is currently accepting new patients.
Her clinical research consists of co-authoring 2 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
100 Hitchcock Way, Manchester, NH 03104
1 Medical Ctr Dr, Lebanon, NH 03756
53 Fairview St, Brattleboro, VT 05301
1080 Hospital Dr, Saint Johnsbury, VT 05819
580 Court St, Keene, NH 03431
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Brigham And Women's Hospital, Department Of Radiation Oncology
Dr. Raymond Mak is an Associate Professor of Radiation Oncology at Harvard Medical School and Director of Clinical Innovation, Thoracic Radiation Oncology Disease Site Leader, and Director of Patient Safety/Quality in the Department of Radiation Oncology at Brigham and Women’s Hospital/Dana-Farber Cancer Institute.Dr. Mak received his undergraduate degree from Cornell University and medical degree from Harvard Medical School, trained at the Harvard Radiation Oncology Residency Program, and is board certified in Radiation Oncology.Dr. Mak has over 10 years of experience in radiation treatment of thoracic malignancies including lung cancer, mesothelioma, and thymomas, and in the clinical application of advanced radiation therapy techniques including stereotactic body radiation therapy. He has applied stereotactic body radiation therapy for novel indications including the treatment of cardiac arrhythmias. He led the implementation of MR-guided radiation therapy and adaptive radiation therapy program at BWH/DFCI in 2019 and has expertise in these innovative new treatment approaches. His research interests focus on developing genomic and imaging biomarkers to predict radiation therapy response and toxicity for lung cancer patients, and applying artificial intelligence techniques to automate radiation therapy planning and improve patient care. He has expertise in developing new methods to reduce the risk of cardiac and pulmonary toxicity for patients receiving radiation therapy. Dr. Mak is rated as a Distinguished provider by MediFind in the treatment of Metastatic Pleural Tumor. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.
Brigham And Women's Hospital, Department Of Radiation Oncology
Shyam Tanguturi is a Radiation Oncologist in Boston, Massachusetts. Dr. Tanguturi is rated as a Distinguished provider by MediFind in the treatment of Metastatic Pleural Tumor. His top areas of expertise are Astrocytoma, Glioblastoma, Posterior Fossa Tumor, and Primitive Neuroectodermal Tumor (PNET).
Brigham And Women's Hospital, Department Of Radiation Oncology
David Kozono is a Radiation Oncologist in Boston, Massachusetts. Dr. Kozono is rated as a Distinguished provider by MediFind in the treatment of Metastatic Pleural Tumor. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AngiosarcomaDr. Fariss isDistinguished. Learn about Angiosarcoma.
- Advanced
- Breast CancerDr. Fariss isAdvanced. Learn about Breast Cancer.
- Endometrial CancerDr. Fariss isAdvanced. Learn about Endometrial Cancer.
- Endometrial Stromal SarcomaDr. Fariss isAdvanced. Learn about Endometrial Stromal Sarcoma.
- Vulvar CancerDr. Fariss isAdvanced. Learn about Vulvar Cancer.
- Experienced
- Acinic Cell Carcinoma of Salivary Glands
- ALK-Positive Non-Small Cell Lung CancerDr. Fariss isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Bone TumorDr. Fariss isExperienced. Learn about Bone Tumor.
- Breast Cancer in MenDr. Fariss isExperienced. Learn about Breast Cancer in Men.
- Cervical CancerDr. Fariss isExperienced. Learn about Cervical Cancer.
- Dry MouthDr. Fariss isExperienced. Learn about Dry Mouth.


